Avalo Therapeutics, Inc.
AVTX· Nasdaq
Released May 9, 2017, during market hours
10-Q filed May 9, 2017, 39 days after period end · 0001628280-17-005206
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|
| Revenue | $384.00 | — | — | — |
| Net Income | -$1.96M | -$5.14M | -$3.24M | -$3.63M |
| EPS Diluted | -$0.19 | -$0.59 |
Avalo Therapeutics, Inc. · CIK 1534120 · Engraved from SEC EDGAR
| -$4.98 |
| -$5.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.